NLRP3 and steatosis: Aggan et al. found elevated serum NLRP3 levels in patients with HCV, which were associated with liver pathological changes, proposing serum NLRP3 levels as a biomarker for hepatic necroinflammatory changes, fibrosis, and steatosis (Aggan et al., 2022).